Trial NCT00985621

View at ClinicalTrials.gov 
Org. Study IDs: A4091030
Secondary IDs: 2009-013329-41 OA OXY STUDY

Last trial update was posted on 2021-05-14

MeSH Interventions

Oxycodone Tanezumab

MeSH Conditions

Osteoarthritis

Other Conditions


Stopping Reasons

See termination reason in detailed description.

Limitations And Caveats

Due to the US FDA imposed clinical hold (effective 23 June 2010), study was terminated early and planned sample size was not reached. The primary time-point was changed from Week 16 to Week 8, as per change in planned analysis.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID